Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB-Reference-Cited by-同舟云学术

Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB

Published:2019-05-04 Issue:5 Volume:16 Page:525-538
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Sankhe Kaksha¹,Khan Tabassum¹,Bhavsar Chintan²^ORCID,Momin Munira²^ORCID,Omri Abdelwahab³^ORCID

Affiliation:

1. Department of Pharm Chem and QA, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India

2. Department of Pharmaceutics, SVKM’s Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India

3. Department of Chemistry & Biochemistry, Laurentian University, Sudbury, Canada

Funder

No funding to declare

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2019.1609937

Reference86 articles.

1. World Health Organization. Global tuberculosis report 2018. World Health Organization; 2018.

2. Centers for Disease Control and Prevention (U.S.) N, National Center for Infectious Diseases (U.S.) N, Shah N, et al. Emerging infectious diseases. 387. Centers for Disease Control and Prevention (CDC); 1995

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Delivery Strategies of Nintedanib for Lung Disorders and Beyond: A Comprehensive Review;AAPS PharmSciTech;2024-07-01

2. Automated SEM/EDX imaging for the in-depth characterization of non-exhaust traffic emissions from the Munich subway system;Science of The Total Environment;2024-03

3. Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis;Journal of Drug Delivery Science and Technology;2022-09

4. Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer;Nanomedicine;2022-06

5. A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases;Journal of Nanobiotechnology;2022-03-03